ICL Group Ltd Dossier
Qualitative Analysis
Business overview
ICL Group Ltd. (formerly Israel Chemicals Ltd.) is a leading global specialty minerals and chemicals company. The company operates a highly integrated business model utilizing unique mineral resources, primarily bromine, potash, and phosphate. Its operations are organized into four core business segments: Industrial Products (producing bromine and bromine-based compounds), Potash (producing potash, salt, magnesium, and electricity), Phosphate Solutions (utilizing phosphate commodities to produce specialty products, food ingredients, and fertilizers), and Growing Solutions (developing specialty fertilizers, biostimulants, and digital agricultural platforms). ICL is dual-listed on the New York Stock Exchange (NYSE) and the Tel Aviv Stock Exchange (TASE).
Research as of 19 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Executing against strategy to accelerate growth in specialty crop nutrition and specialty food solutions, including the acquisition of Bartek Ingredients and the establishment of a specialty fertilizer production facility in India.
Expected impact: Designed to help fund the company's profitable growth engines – specialty crop nutrition and specialty food solutions.
Launching Sulfurball, the first spherical-format sulfur fertilizer in Latin America, to advance nutrient efficiency and soil restoration.
Expected impact: Redefines the regional specialty fertilizer landscape and positions Latin America as a rising hub for sustainable and high-efficiency nutrient solutions.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Recent Acquisitions
Acquisition of approximately 50% of Bartek Ingredients (with a second phase for full ownership subject to milestones) to expand deeper into global specialty food solutions. Bartek is a global leader in food-grade malic and fumaric acid.
Financial impact: Adds approximately $65 million in annual revenue, with double-digit EPS accretion targeted post-integration.
Acquisition of substantially all business activities of Lavie Bio (a subsidiary of Evogene) for $15.25 million and Evogene's MicroBoost AI for AG platform for $3.5 million. Strengthens ICL's ag-biologicals innovation capabilities and AI-driven solutions.
Financial impact: Provides a scalable AI-powered biologicals engine to accelerate microbial product development and expand the sustainable agriculture product pipeline.
Acquisition of a North American provider of customized liquid and dry agricultural fertilizer formulations to expand Growing Solutions product offerings and coast-to-coast service.
Financial impact: Expands U.S. footprint with two manufacturing facilities in California and Georgia, enabling same-day shipping to key growing regions.
Acquisition of a Brazilian manufacturer, developer, and provider of biologicals to expand ICL's biologicals portfolio and specialty plant nutrition market share in Brazil.
Financial impact: Positions the company for further expansions into new and adjacent biological end-markets in South America.
Strategic Partnerships
Ensures the availability of ICL's specialty water-soluble fertilizers for drip irrigation of high-value crops in China, which is the world's largest market for fertigation.
Terms: Valued at approximately $170 million, running through 2028.